Furuta, A., Suzuki, Y., Hayashi, N., Egawa, S
Baltimore, MD: Lippincott Williams & Wilkins
The well-documented association between metabolic conditions, such as type 2 diabetes mellitus (T2DM) and obesity, and the risk of dementia has created opportunities for repurposing metabolic drugs for neurological disorders (Long and Holtzman, 2019)
Challenges in affordability help explain why many Americans turn to companies like Hims & Hers in the first place, yet patients end up navigating an increasingly confusing health care landscape, subject to disruptions from legal and economic battles beyond their control